Advertisement
Cerus Corporation

Cerus Corporation (CERS) Stock Overview

Explore Cerus Corporation’s financial performance, market position, analyst ratings, and future outlook.

CERSNASDAQ
HealthcareMedical - Devices
$2.58
$0.02(0.96%)
U.S. Market is Open · 13:25
Advertisement

Cerus Corporation (CERS)

Meyka AI Score

Z

Key Financials

Market Cap517M
P/E Ratio-52.75
EPS (TTM)$-0.05
ROE-0.15%
Fundamental Analysis

AI Price Forecasts

1 Month$2.05
3 Months$2.69
1 Year Target$1.88

CERS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cerus Corporation (CERS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 50.37, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.88.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -52.75 and a market capitalization of 517M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.77%
5-Day Change
-4.44%
1-Month Change
-1.15%
3-Month Change
33.68%
6-Month Change
38.71%
Year-to-Date (YTD) Change
25.24%
1-Year Change
75.51%
3-Year Change
2.38%
5-Year Change
-54.17%
All-Time (Max) Change
-78.72%

Contact Information

925 288 6000
1220 Concord Avenue, Concord, CA, 94520

Company Facts

614 Employees
IPO DateJan 31, 1997
CountryUS
Actively Trading

Frequently Asked Questions